Anixa Biosciences Says COVID-19 Compounds Potentially Effective Against Omicron Variant


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Anixa Biosciences Inc (NASDAQ:ANIXannounced the results of a genomic variant analysis conducted with its partner, MolGenie GmbH, on potential compounds to treat COVID-19. 

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

  • The data indicate that the compounds in development should be effective against the Omicron variant, in addition to the previously identified Delta variant of the virus. 
  • Related Link: Anixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variant.
  • Anixa and MolGenie are developing compounds for the potential treatment of COVID-19 with the long-term goal of creating an inexpensive, orally-administered room temperature-stable pill for the outpatient setting. 
  • The program focuses on identifying novel, small molecule inhibitors of Mpro, the main protease of the SARS-CoV-2 virus, necessary for replication. 
  • The current compounds that Anixa and MolGenie have synthesized and tested have demonstrated the ability to inhibit the function of this protein with favorable potency comparable to authorized therapies.
  • Price Action: ANIX shares are up 1.60% at $3.18 during the market session on the last check Tuesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: BiotechLong IdeasNewsPenny StocksHealth CareMoversTrading IdeasGeneralBriefsCOVID-19 CoronavirusPreclinical Phase